AVOBENZONE, OCTISALATE, AND OCTOCRYLENE

N/A

Manufactured by Alchemee, LLC

2,163 FDA adverse event reports analyzed

Last updated: 2026-04-15

About AVOBENZONE, OCTISALATE, AND OCTOCRYLENE

AVOBENZONE, OCTISALATE, AND OCTOCRYLENE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Alchemee, LLC. The most commonly reported adverse reactions for AVOBENZONE, OCTISALATE, AND OCTOCRYLENE include DRUG INEFFECTIVE, ACNE, SKIN BURNING SENSATION, DRY SKIN, ERYTHEMA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for AVOBENZONE, OCTISALATE, AND OCTOCRYLENE.

Top Adverse Reactions

DRUG INEFFECTIVE318 reports
ACNE258 reports
SKIN BURNING SENSATION236 reports
DRY SKIN217 reports
ERYTHEMA178 reports
SKIN IRRITATION148 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION95 reports
SKIN EXFOLIATION90 reports
HYPERSENSITIVITY69 reports
OVERDOSE61 reports
RASH55 reports
PAIN OF SKIN52 reports
CONDITION AGGRAVATED39 reports
PRURITUS37 reports
UNDERDOSE33 reports
SENSITIVE SKIN23 reports
RASH MACULAR20 reports
PRODUCT USE IN UNAPPROVED INDICATION16 reports
CHEMICAL BURN OF SKIN14 reports
SKIN SWELLING13 reports
SKIN DISCOMFORT12 reports
URTICARIA12 reports
PRODUCT USE ISSUE11 reports
SEBORRHOEA11 reports
SKIN DISCOLOURATION11 reports
SCAR10 reports
DERMATITIS8 reports
SKIN FISSURES8 reports
SWELLING FACE8 reports
PARAESTHESIA7 reports
RASH ERYTHEMATOUS7 reports
RASH PAPULAR7 reports
EYE SWELLING4 reports
PERIORBITAL SWELLING4 reports
SKIN HYPERPIGMENTATION4 reports
BLISTER3 reports
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION3 reports
SCAB3 reports
ACNE CYSTIC2 reports
APPLICATION SITE ERYTHEMA2 reports
ECZEMA2 reports
EXPOSURE DURING PREGNANCY2 reports
EYE IRRITATION2 reports
FEELING HOT2 reports
OCULAR HYPERAEMIA2 reports
SKIN HAEMORRHAGE2 reports
SKIN HYPOPIGMENTATION2 reports
SKIN INJURY2 reports
ACCIDENTAL EXPOSURE TO PRODUCT1 reports
APPLICATION SITE DRYNESS1 reports
APPLICATION SITE HYPERSENSITIVITY1 reports
APPLICATION SITE IRRITATION1 reports
APPLICATION SITE PAIN1 reports
BRAIN NEOPLASM1 reports
CHEMICAL PEEL OF SKIN1 reports
CONTUSION1 reports
DENTAL CARIES1 reports
DRY EYE1 reports
ECZEMA EYELIDS1 reports
EYE ALLERGY1 reports
EYELID IRRITATION1 reports
FLUSHING1 reports
HAEMORRHAGE1 reports
ILLNESS1 reports
LIP DRY1 reports
LIP SWELLING1 reports
MIGRAINE1 reports
NEOPLASM MALIGNANT1 reports
PAIN1 reports
PANCREATIC CARCINOMA1 reports
PERIORBITAL INFLAMMATION1 reports
PERIORBITAL IRRITATION1 reports
PERIORBITAL PAIN1 reports
PHARYNGEAL SWELLING1 reports
PSORIASIS1 reports
RASH GENERALISED1 reports
SKIN ABRASION1 reports
SKIN CANCER1 reports
SKIN LACERATION1 reports
SKIN MASS1 reports
SKIN TIGHTNESS1 reports
SKIN WRINKLING1 reports
SNEEZING1 reports
SUBCUTANEOUS ABSCESS1 reports
SWELLING OF EYELID1 reports
THROAT IRRITATION1 reports

Report Outcomes

Out of 999 classified reports for AVOBENZONE, OCTISALATE, AND OCTOCRYLENE:

Serious 0.4%Non-Serious 99.6%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female4 (100.0%)

Reports by Age

Age 441 reports
Age 511 reports
Age 701 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with AVOBENZONE, OCTISALATE, AND OCTOCRYLENE?

This profile reflects 2,163 FDA FAERS reports that mention AVOBENZONE, OCTISALATE, AND OCTOCRYLENE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for AVOBENZONE, OCTISALATE, AND OCTOCRYLENE?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, ACNE, SKIN BURNING SENSATION, DRY SKIN, ERYTHEMA, SKIN IRRITATION. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures AVOBENZONE, OCTISALATE, AND OCTOCRYLENE?

Labeling and FAERS entries often list Alchemee, LLC in connection with AVOBENZONE, OCTISALATE, AND OCTOCRYLENE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.